News • To enter human cells
SARS-CoV-2 hijacks antiviral human proteins
SARS-CoV-2 depends on the broadly antiviral interferon-induced human transmembrane proteins , to enter human cells and replicate inside them.
Virus
News • After hospitalization
Covid: two years later, half of patients still have symptoms
Two years after infection with COVID-19, half of patients who were admitted to hospitals still have at least one symptom, according to the longest follow-up study to date.
News • mhealth
Smartphone-powered microchip for at-home diagnostic testing
Researchers developed a new microfluidic chip with broad applications for detecting viruses, pathogens, bacteria and other biomarkers in liquid samples.
News • HHV awaken via microRNA
Why herpes keeps coming back
Dormant herpesviruses induce their reactivation via a previously unknown cellular mechanism mediated by a viral microRNA, Würzburg researchers discovered.
News • UV sterilization
Ultraviolet disinfection against Covid-19: Study gives new insights
UV radiation is one of the go-to methods for preventing the spread of SARS-CoV-2. But what UV dosage kills the virus? What wavelength? How long? A new study answers many of those questions.
News • Coronavirus census
WHO: Covid-19 pandemic claimed almost 15 million lives
In 2020 and 2021, the death toll associated with Covid-19 was approximately 14.9 million, according to the World Health Organization. However, the global distribution has been far from equal.
News • Cognitive impairment after infection
Severe Covid-19 can 'age' our brain by 20 years, study finds
Cognitive impairment as a result of severe Covid-19 is similar to that sustained between 50 and 70 years of age and is the equivalent to losing 10 IQ points, scientists found.
News • Viral aftereffects
Long Covid: Six in ten have at least one symptom one year after infection
Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.
Article • UHPLC-MS/MS analysis
Predicting Covid-19 infection severity with mass spec
Using mass spectrometry and chromatography techniques, UK researchers have developed an approach to predict infection severity among Covid-19 patients, as well as potential outcomes.
News • Global study finds increase in deaths
Why is Covid-19 more deadly on weekends?
A global analysis of nearly 6 million Covid-19 deaths finds an increase in mortality at weekends compared to weekdays. Bureaucratic and reporting delays alone do not explain this, researchers report.
News • Effective prevention
Covid-19 vaccination greatly reduces infectious viral load
By comparing the infectious viral load caused by ancestral SARS-CoV-2 as well as by the Delta and Omicron variants, scientists highlight the benefits of vaccination.
News • Mini-livers on a chip
Organoids: step towards hepatitis C vaccine
A platform for studying how the human immune system responds to hepatitis C infection by combining microfluidic technology with liver organoids could speed the hunt for a vaccine.
News • In 2020
COVID-19 restrictions linked to 750,000 fewer dengue cases
COVID-19 measures such as school closures and ‘high-traffic and mixing’ areas had the strongest association, providing clues for new intervention approaches.
News • Adaptable for screening
An optical methodology for rapid detection of COVID-19
The tool has made it possible to detect SARS-CoV-2 in exudate from symptomatic patients with a sensitivity of 100% and a specificity of 87.5%
News • Alternative to injection
Inhaled vaccine delivers broad protection against SARS-CoV-2
Scientists have confirmed that an inhaled form of COVID vaccine can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern.
News • COVID and E. coli
Futuristic coating for fabrics kills viruses
Researchers have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of the virus that causes COVID-19 by up to 90 per cent.
News • Hard to break down
Hepatitis E: Most common hand infectants no match for HEV
Scientists have investigated the effectiveness of various common hand disinfectants against hepatitis E. They were able to show that most formulations do not completely inactivate the virus.
News • Autohaem smear and smear+
Automating blood smears for malaria diagnosis
Researchers have developed a device that removes one of the biggest bottlenecks preventing quick, reliable malaria diagnosis.
News • Multiple sclerosis
Epstein-Barr virus may be leading cause of MS
A connection between the Epstein-Barr virus and multiple sclerosis has long been suspected. A new study provides ‘compelling evidence of causality’.
News • Without causing neurological damage
Injections of zika virus destroys brain tumors
In both the mice and organoids, cytokines suppressed tumor growth after treatment, and defense cells migrated to the brain region affected by the tumor, alerting the immune system to its existence.
News • Potential game-changer
Telling COVID-19 apart from influenza
Researchers have developed a diagnostic for SARS-CoV-2 that is capable of differentiating between COVID-19 and the garden-variety bug with fast turnaround.
News • Research
Quantum sensor to detect SARS-CoV-2 faster
Scientists at have designed a quantum sensor to detect SARS-CoV-2 faster, cheaper, and more accurate than the current gold-standard technique, PCR.
News • New study
Antibodies can neutralize omicron
An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants.
News • COVID-19
Chewing gum could reduce SARS-CoV-2 transmission
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus.
News • Rapid detection
Molecular diagnostic test for Covid-19, Flu, RSV receives CE mark
A new rapid molecular diagnostic test from Cepheid has received the CE mark for distribution in the European market. The test, called Xpert Xpress CoV-2/Flu/RSV plus, is designed for qualitative detection of the viruses causing Covid-19, Flu A, Flu B, and respiratory syncytial virus (RSV) infections from a single patient sample. The new plus version of the test provides a third gene target for…